Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging Study of Fear Learning: Effects of Estrogen
NCT07737613Phase 1Not yet recruiting
- Sponsor
- University of Arizona
- Start
- Aug 2026
- Primary completion
- Aug 2027
01
Overview
Phase 1, open-label, single-arm trial of estradiol in post-traumatic stress disorder (PTSD) and No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity, sponsored by University of Arizona. Primary endpoint: Neural Response to Fear Conditioning Task at 4 hours. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
estradiol
03
Conditions
post-traumatic stress disorder (PTSD)No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.
Beyond the preview
Go deeper on NCT07737613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737613.